Amgen's acquisition of Horizon Therapeutics sanctioned by Irish High Court

AMGEN INC

Irish High Court sanctioned the scheme of arrangement on October 5, 2023, moving deal closer to completion.
Completion remains subject to delivery of the court order to the Registrar of Companies in Ireland.
Deal originally announced December 11, 2022, valued at ~$27.8B.

item 8.01

AMGEN INC filing history →

Source: SEC EDGAR

accession 0001193125-23-251090

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.